Functions, aberrations, and advances for chromatin modulation in cancer
Related Experiment Video
Updated: May 7, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Mariarosaria Conte1, Lucia Altucci
1Dipartimento di Biochimica, Biofisica e Patologia generale, Seconda Università di Napoli, Vico L. De Crecchio 7, 80138, Naples, Italy.
Abstract:
Cancer initiation and progression is causally connected to genome and epigenome deregulations. Epigenetic deregulations (such as DNA methylation, histone modifications, and miRNA-based modulation) have been increasingly reported in tumorigenesis and different chromatin-modulating enzymes have been discovered and classified and their aberrations connected to cancer. A better insight into alterations occurring on chromatin enzymes and their impact in cancer thus represents a crucial step in exploiting epigenetic targeting in cancer prevention and treatment.
Insights
Cancer development is linked to epigenetic changes. Understanding alterations in chromatin enzymes is key for developing new cancer prevention and treatment strategies targeting epigenetics.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer initiation and progression are linked to genome and epigenome deregulation.
- Epigenetic alterations, including DNA methylation, histone modifications, and miRNA modulation, are increasingly implicated in tumorigenesis.
- Various chromatin-modulating enzymes have been identified and their aberrations associated with cancer development.
Purpose of the Study:
- To explore the alterations occurring in chromatin enzymes.
- To understand the impact of these chromatin enzyme alterations in cancer.
- To highlight the importance of epigenetic targeting for cancer prevention and treatment.
Main Methods:
- Review of existing literature on epigenetic deregulation in cancer.
- Classification of chromatin-modulating enzymes.
- Analysis of the connection between enzyme aberrations and cancer pathology.
Main Results:
- Epigenetic deregulation is a significant factor in cancer initiation and progression.
- Specific chromatin-modulating enzymes and their aberrant functions are identified in various cancers.
- Understanding these alterations provides a basis for targeted epigenetic therapies.
Conclusions:
- Insights into chromatin enzyme alterations are crucial for advancing epigenetic cancer therapy.
- Targeting epigenetic mechanisms offers promising avenues for cancer prevention and treatment.
- Further research into chromatin enzyme functions in cancer is warranted.
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

